The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Rivaroxaban Clonmel 15 mg film-coated tablets Rivaroxaban Clonmel 20 mg film-coated tablets



Clonmel Healthcare LtdPA0126/035/005

Main Information

Trade NameRivaroxaban Clonmel 15 mg film-coated tablets Rivaroxaban Clonmel 20 mg film-coated tablets
Active SubstancesRivaroxaban
Rivaroxaban
Dosage FormFilm-coated tablet
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/035/005

Group Information

ATC CodeB01AF01 rivaroxaban

Status

License statusAuthorised
Licence Issued13/01/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back